Abstract
Background
Methods
Results
SUPPLEMENTARY MATERIALS
Notes
REFERENCES
Table 1.
Characteristic | BMI <18.5 kg/m2 | 18.5≤ BMI <23 kg/m2 | 23≤ BMI <25 kg/m2 | 25≤ BMI <30 kg/m2 | 30 kg/m2 ≤BMI | P value |
---|---|---|---|---|---|---|
Number | 28,229 | 509,859 | 530,544 | 868,707 | 148,848 | |
Age, yr | 62.09±12.3 | 59.67±10.78 | 59.01±10.23 | 58.03±10.2 | 55.96±10.37 | <0.0001 |
40–64 | 16,058 (56.88) | 338,673 (66.42) | 368,290 (69.42) | 629,148 (72.42) | 115,704 (77.73) | <0.0001 |
≥65 | 12,171 (43.12) | 171,186 (33.58) | 162,254 (30.58) | 239,559 (27.58) | 33,144 (22.27) | |
Male sex | 17,210 (60.97) | 304,295 (59.68) | 334,282 (63.01) | 531,476 (61.18) | 67,657 (45.45) | <0.0001 |
BMI, kg/m² | 17.45±0.93 | 21.43±1.13 | 23.97±0.57 | 26.89±1.33 | 32.17±6.09 | <0.0001 |
Height, cm | 161.23±8.99 | 161.9±8.68 | 162.55±8.78 | 162.51±9.05 | 160.73±9.67 | <0.0001 |
Body weight, kg | 45.51±5.67 | 56.34±6.79 | 63.54±7.01 | 71.21±8.55 | 83.28±11.07 | <0.0001 |
Waist circumference, cm | 70.19±7.61 | 78.15±6.27 | 83.54±5.98 | 89.2±6.24 | 98.45±7.83 | <0.0001 |
Low income | 7,639 (27.06) | 122,502 (24.03) | 121,345 (22.87) | 197,752 (22.76) | 36,280 (24.37) | <0.0001 |
Current smoker | 9,820 (34.79) | 139,604 (27.38) | 130,901 (24.67) | 197,042 (22.68) | 28,173 (18.93) | <0.0001 |
Heavy drinker | 2,600 (9.21) | 45,316 (8.89) | 49,937 (9.41) | 89,985 (10.36) | 13,616 (9.15) | <0.0001 |
Physical activity | 4,639 (16.43) | 112,193 (22) | 121,503 (22.9) | 186,105 (21.42) | 25,595 (17.2) | <0.0001 |
Hypertension | 11,423 (40.47) | 244,545 (47.96) | 295,440 (55.69) | 556,031 (64.01) | 111,842 (75.14) | <0.0001 |
Dyslipidemia | 6,688 (23.69) | 182,595 (35.81) | 224,006 (42.22) | 405,561 (46.69) | 77,205 (51.87) | <0.0001 |
Cancer | 1,194 (4.23) | 14,623 (2.87) | 12,135 (2.29) | 17,799 (2.05) | 2,871 (1.93) | <0.0001 |
Chronic kidney disease | 3,445 (12.2) | 57,084 (11.2) | 60,285 (11.36) | 101,953 (11.74) | 18,230 (12.25) | <0.0001 |
Cardiovascular disease | 2,728 (9.66) | 53,985 (10.59) | 62,772 (11.83) | 111,034 (12.78) | 20,882 (14.03) | <0.0001 |
Insulin use | 4,421 (15.66) | 56,338 (11.05) | 47,772 (9) | 70,239 (8.09) | 12,141 (8.16) | <0.0001 |
Use of three or more oral hypoglycemic agents | 4,700 (16.65) | 84,861 (16.64) | 80,695 (15.21) | 123,495 (14.22) | 22,173 (14.9) | <0.0001 |
Duration of DM ≥5 years | 9,205 (32.61) | 183,415 (35.97) | 176,795 (33.32) | 252,666 (29.09) | 38,126 (25.61) | <0.0001 |
Systolic BP, mm Hg | 122.99±17.6 | 126.35±16.19 | 128.63±15.59 | 130.7±15.42 | 133.61±15.92 | <0.0001 |
Diastolic BP, mm Hg | 75.62±10.95 | 77.08±10.19 | 78.58±10.01 | 80.19±10.1 | 82.36±10.54 | <0.0001 |
Fasting glucose, mg/dL | 153.75±67.6 | 146.7±51.7 | 144.2±45.82 | 142.98±42.78 | 143.4±42.73 | <0.0001 |
Total cholesterol | 184.72±45.72 | 192.44±44.79 | 196.34±46.67 | 198.8±46.32 | 201.05±45.57 | <0.0001 |
HDL-cholesterol, mg/dL | 59.06±30.67 | 54.6±30.55 | 51.9±26.64 | 50.8±29.38 | 50.8±27.76 | <0.0001 |
LDL-cholesterol, mg/dL | 103.47±76.46 | 110.79±76.82 | 112.93±75.88 | 113.55±79.32 | 114.96±78.4 | <0.0001 |
Triglyceride, mg/dLa | 103.04 (102.38–103.71) | 124.31 (124.11–124.5) | 144.28 (144.07–144.5) | 158.7 (158.52–158.89) | 164.75 (164.31–165.19) | <0.0001 |
Table 2.
Model 1: unadjusted; Model 2: adjusted for age, sex, smoke, drink, regular exercise; Model 3, adjusted for model 2 plus hypertension, dyslipidemia, chronic kidney disease, insulin use, duration of diabetes mellitus ≥5 years, use of three or more oral hypoglycemic agents, fasting glucose level, and height.
BMI, body mass index; IR, incidence rate; HR, hazard ratio; CI, confidence interval.
Table 3.
Adjusted for age, sex, smoke, drink, regular exercise, hypertension, dyslipidemia, chronic kidney disease, insulin use, duration of diabetes mellitus ≥5 years, combinations ≥3 classes of oral antidiabetic agent, fasting glucose level, and height.
BMI, body mass index; IR, incidence rate; HR, hazard ratio.